GPT and metabolic dysfunction-associated steatotic liver disease: For example, dietary n-3 PUFA consumption (2 g/day) for six months significantly improves human non-alcoholic fatty liver disease in subjects with decreased plasma alanine aminotransferase (ALT), TAG and TNF-α and homeostasis model assessment [182].